HF
HUMA icon

HRT Financial’s Humacyte HUMA Stock Holding History

HRT Financial’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$850K Buy
+1,089,508
New +$1.01M ﹤0.01% 2267
2025
Q2 		– Sell
-131,524
Closed -$224K – 3029
2025
Q1 		$224K Buy
+131,524
New +$494K ﹤0.01% 1941
2024
Q4 		– Sell
-49,416
Closed -$268K – 2760
2024
Q3 		$268K Buy
+49,416
New +$326K ﹤0.01% 1845
2022
Q3 		– Sell
-58,632
Closed -$188K – 3105
2022
Q2 		$188K Buy
+58,632
New +$326K ﹤0.01% 2266
2021
Q4 		– Sell
-22,229
Closed -$258K – 3572
2021
Q3 		$258K Buy
+22,229
New +$254K ﹤0.01% 2516

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HRT Financial's HUMA Position: Q2 2026 in Review

HRT Financial opened a new position in Humacyte (HUMA) in Q2 2026: 1,089,508 shares worth $850K. The stake represents ﹤0.01% of the portfolio and ranks #2267 among its holdings. This is a return to the name: HRT Financial previously reported a position in HUMA as recently as Q1 2025.

HRT Financial first reported a position in HUMA in Q3 2021 and has held it in 5 quarters since. 164 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • HRT Financial held 1,089,508 shares of Humacyte worth $850K as of Q2 2026.
  • Humacyte was a new HRT Financial position in Q2 2026.
  • Humacyte made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2267 holding.
  • HRT Financial first reported a position in Humacyte in Q3 2021 and has held it in 5 quarters since.
  • 164 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.